Qube Research & Technologies (QRT)
ITCI

Qube Research & Technologies (QRT)’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-931,330
Closed -$123M – 4096
2025
Q1 		$123M Buy
931,330
+677,633
+267% +$84.4M 0.14% 175
2024
Q4 		$21.2M Buy
253,697
+56,838
+29% +$4.67M 0.03% 697
2024
Q3 		$14.4M Sell
196,859
-81,715
-29% -$6.14M 0.02% 824
2024
Q2 		$19.1M Buy
278,574
+190,196
+215% +$13.2M 0.03% 619
2024
Q1 		$6.12M Buy
88,378
+78,180
+767% +$5.37M 0.01% 1116
2023
Q4 		$730K Sell
10,198
-46,091
-82% -$2.65M ﹤0.01% 2097
2023
Q3 		$2.93M Buy
56,289
+43,385
+336% +$2.53M 0.01% 1187
2023
Q2 		$817K Sell
12,904
-19,165
-60% -$1.19M ﹤0.01% 1381
2023
Q1 		$1.74M Buy
+32,069
New +$1.55M 0.01% 1066
2021
Q3 		– Sell
-10,046
Closed -$410K – 2887
2021
Q2 		$410K Sell
10,046
-13,114
-57% -$485K ﹤0.01% 1387
2021
Q1 		$786K Sell
23,160
-27,523
-54% -$955K 0.01% 954
2020
Q4 		$1.61M Buy
50,683
+36,607
+260% +$962K 0.02% 703
2020
Q3 		$361K Buy
+14,076
New +$321K 0.01% 1164

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ITCI Position: Q2 2025 in Review

Qube Research & Technologies (QRT) sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 931,330 shares — an estimated $123M sold.

Qube Research & Technologies (QRT) first reported a position in ITCI in Q3 2020 and held it in 13 quarters. The position peaked at $123M in Q1 2025. 3 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • Qube Research & Technologies (QRT) reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 931,330 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $123M.
  • Qube Research & Technologies (QRT) first reported a position in Intra-Cellular Therapies Inc. in Q3 2020 and held it in 13 quarters.
  • Qube Research & Technologies (QRT)'s Intra-Cellular Therapies Inc. position peaked at $123M in Q1 2025.
  • 3 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2025, filed 14 Aug 2025.